Structure-activity relationships and specificity of inhibition of DNA polymerases from normal and leukemia cells of man and from simian sarcoma virus by rifamycin derivatives.
D004253:DNA Nucleotidylexotransferase / Q000037:antagonists & inhibitors; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors; D004258:DNA Polymerase III / Q000037:antagonists & inhibitors; D006801:Humans; D066298:In Vitro Techniques; D007945:Leukemia, Lymphoid / Q000201:enzymology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000201:enzymology*; D019384:Nucleic Acid Synthesis Inhibitors; D010835:Phytohemagglutinins / Q000494:pharmacology; D012190:Retroviridae / Q000201:enzymology*; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins / Q000494:pharmacology*; D012842:Sarcoma Virus, Woolly Monkey / Q000201:enzymology*; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013329:Structure-Activity Relationship
D019384:Nucleic Acid Synthesis Inhibitors; D010835:Phytohemagglutinins; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins; D012710:Serum Albumin, Bovine; D004253:DNA Nucleotidylexotransferase; D004256:DNA Polymerase I; D004257:DNA Polymerase II; D004258:DNA Polymerase III